Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Retained Earnings (2016 - 2026)

Organogenesis Holdings has reported Retained Earnings over the past 11 years, most recently at -$3.1 million for Q4 2025.

  • For Q4 2025, Retained Earnings rose 92.33% year-over-year to -$3.1 million; the TTM value through Dec 2025 reached -$3.1 million, up 92.33%, while the annual FY2025 figure was -$3.1 million, 92.33% up from the prior year.
  • Retained Earnings for Q4 2025 was -$3.1 million at Organogenesis Holdings, up from -$46.8 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$3.1 million in Q4 2025 and troughed at -$140.8 million in Q1 2021.
  • A 5-year average of -$59.4 million and a median of -$50.8 million in 2022 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: crashed 37.97% in 2024 and later skyrocketed 92.33% in 2025.
  • Year by year, Retained Earnings stood at -$60.8 million in 2021, then rose by 25.53% to -$45.3 million in 2022, then increased by 9.56% to -$41.0 million in 2023, then increased by 2.1% to -$40.1 million in 2024, then skyrocketed by 92.33% to -$3.1 million in 2025.
  • Business Quant data shows Retained Earnings for ORGO at -$3.1 million in Q4 2025, -$46.8 million in Q3 2025, and -$68.3 million in Q2 2025.